Gopal Ramakrishnan

Gopal Ramakrishnan is a Scientist and Project Manager at Targazyme, where Gopal works on developing Next-Generation Potentially Curative Immunotherapies for Late-Stage Liquid and Solid Cancers. Prior to this role, Gopal also served as a Research And Development Scientist at Shield T3 LLC, a Research Assistant Professor at the University of Illinois Chicago, and a Postdoctoral Researcher at the University of Mississippi Medical Center. Gopal holds a Doctor of Philosophy - PhD in Biochemistry from All India Institute of Medical Sciences and a Master's degree in Molecular and Human Genetics from Banaras Hindu University.